Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc. (KURA), sold 1,548 shares at $13.89 ($22K) on 2023-01-27, disclosed to the SEC on 2023-01-31.
Open-market sale of $22k KURA by SVP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.89 | 682 | $9K | 44.1% |
| 2 | $13.89 | 866 | $12K | 55.9% |
| Total | $13.89 avg | 1,548 | $22K | 100% |
| Filing → |
| KURA | SELL | 2025-11-14 | $101K | — | Filing → |
| KURA | SELL | 2025-09-29 | $41K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |